Kenneth S. Abramowitz is a Managing General Partner and co-founder of NGN Capital, a $250 million worldwide healthcare venture capital fund. He joined NGN from The Carlyle Group in New York where he was Managing Director from 2001 to 2003, focused on U.S. buyout opportunities in the healthcare industry. Prior to joining Carlyle, Mr. Abramowitz worked as an Analyst at Sanford C. Bernstein & Co. where he covered the medical-supply, hospital-management and HMO industries for 23 years.
Mr. Abramowitz has published several notable studies on healthcare service companies, major medical mergers and cardiovascular device innovation, among others. Mr. Abramowitz earned a B.A. from Columbia University in 1972 and an M.B.A. from Harvard Business School in 1976. Mr. Abramowitz currently sits on the Board of Directors of EKOS Corp., OptiScan Biomedical Corp., Valtech Ltd., and Small Bone Innovations, Inc.
1. Jerusalem has been the capital city of the Jewish people (but no one else) for 3,000 years, including both ancient Israel and current Israel. There...
An Iranian revolutionary court has sentenced well-known Iranian rapper Toomaj Salehi to death for charges linked to Iran's 2022-23 unrest, his lawyer told Iranian newspaper Sharq on Wednesday.
Salehi in his...
US forces in Iraq and Syria faced two separate rocket and explosive drone attacks in less than 24 hours, Iraqi security sources and US officials told Reuters on Monday, the...
Kenneth S. Abramowitz
